Neola Medical AB (publ) (NEOLA.ST)

SEK 2.4

(-4.76%)

EBITDA Summary of Neola Medical AB (publ)

  • Neola Medical AB (publ)'s latest annual EBITDA in 2023 was -7.57 Million SEK , up 16.18% from previous year.
  • Neola Medical AB (publ)'s latest quarterly EBITDA in 2024 Q2 was -2.56 Million SEK , down -20.43% from previous quarter.
  • Neola Medical AB (publ) reported an annual EBITDA of -9.82 Million SEK in 2022, down -33.81% from previous year.
  • Neola Medical AB (publ) reported an annual EBITDA of -6.63 Million SEK in 2021, up 6.42% from previous year.
  • Neola Medical AB (publ) reported a quarterly EBITDA of -2.56 Million SEK for 2024 Q2, down -20.43% from previous quarter.
  • Neola Medical AB (publ) reported a quarterly EBITDA of -2.14 Million SEK for 2023 Q3, up 2.46% from previous quarter.

Annual EBITDA Chart of Neola Medical AB (publ) (2023 - 2018)

Historical Annual EBITDA of Neola Medical AB (publ) (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -7.57 Million SEK 16.18%
2022 -9.82 Million SEK -33.81%
2021 -6.63 Million SEK 6.42%
2020 -6.71 Million SEK -148.65%
2019 -2.59 Million SEK -150.4%
2018 -754 Thousand SEK 0.0%

Peer EBITDA Comparison of Neola Medical AB (publ)

Name EBITDA EBITDA Difference
BrainCool AB (publ) -58.68 Million SEK 87.089%
Nosa Plugs AB -44.97 Million SEK 83.154%